However, recently, Takeuchi and colleagues observed that among 18 juvenile-onset SLE patients, only one exhibited elevated IL-38 levels regardless of lupus nephritis severity, even though the IL-38 levels of that patient decreased after treatment [54]. This evidence concerns the gene IL1F10 and systemic lupus erythematosus.